Artículos de revistas
Molecular mechanisms involved in interleukin 1-beta (IL-1b)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (a-MSH)
Fecha
2013-10Registro en:
Gonzalez, Patricia Verónica; Machado, Ivana Noelia; Vilcaes, Aldo Alejandro; Caruso, Carla Mariana; Roth, German Alfredo; et al.; Molecular mechanisms involved in interleukin 1-beta (IL-1b)-induced memory impairment. Modulation by alpha-melanocyte-stimulating hormone (a-MSH); Elsevier; Brain Behavior And Immunity; 34; 10-2013; 141-150
0889-1591
Autor
Gonzalez, Patricia Verónica
Machado, Ivana Noelia
Vilcaes, Aldo Alejandro
Caruso, Carla Mariana
Roth, German Alfredo
Schiöth, H.
Lasaga, Mercedes Isabel
Scimonelli, Teresa Nieves
Resumen
Pro-inflammatory cytokines can affect cognitive processes such as learning and memory. Particularly, interleukin-1β (IL-1β) influences the consolidation of hippocampus-dependent memories. We previously reported that administration of IL-1β in dorsal hippocampus impaired contextual fear memory consolidation. Different mechanisms have been implicated in the action of IL-1β on long-term potentiation (LTP), but the processes by which this inhibition occurs in vivo remain to be elucidated. We herein report that intrahippocampal injection of IL-1β induced a significant increase in p38 phosphorylation after contextual fear conditioning. Also, treatment with SB203580, an inhibitor of p38, reversed impairment induced by IL-1β on conditioned fear behavior, indicating that this MAPK would be involved in the effect of the cytokine. We also showed that IL-1β administration produced a decrease in glutamate release from dorsal hippocampus synaptosomes and that treatment with SB203580 partially reversed this effect. Our results indicated that IL-1β-induced impairment in memory consolidation could be mediated by a decrease in glutamate release. This hypothesis is sustained by the fact that treatment with d-cycloserine (DCS), a partial agonist of the NMDA receptor, reversed the effect of IL-1β on contextual fear memory. Furthermore, we demonstrated that IL-1β produced a temporal delay in ERK phosphorylation and that DCS administration reversed this effect. We also observed that intrahippocampal injection of IL-1β decreased BDNF expression after contextual fear conditioning. We previously demonstrated that α-MSH reversed the detrimental effect of IL-1β on memory consolidation. The present results demonstrate that α-MSH administration did not modify the decrease in glutamate release induced by IL-1β. However, intrahippocampal injection of α-MSH prevented the effect on ERK phosphorylation and BDNF expression induced by IL-1β after contextual fear conditioning. Therefore, in the present study we determine possible molecular mechanisms involved in the impairment induced by IL-1β on fear memory consolidation. We also established how this effect could be modulated by α-MSH.